Curis (CRIS) Stock Chart & Stock Price History → Never use this word on your phone (FBI could be watching) (From Paradigm Press) (Ad) Free CRIS Stock Alerts $16.36 -0.15 (-0.91%) (As of 05/3/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Curis Stock Price Performance5 Day Performance+11.22%1 Month Performance+2.19%3 Month Performance+59.61%6 Month Performance+257.99%Year-To-Date Performance+28.31%1 Year Performance-2.41% Receive CRIS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Curis and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details CRIS Stock Chart for Saturday, May, 4, 2024 CRIS Chart by TradingView Curis Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/03/2024$16.51$16.36-0.91%$16.78$16.0510,606 shs$96.36 million05/02/2024$15.99$16.51+3.25%$16.99$16.0515,387 shs$97.24 million05/01/2024$15.35$15.99+4.17%$16.30$14.8910,272 shs$94.18 million04/30/2024$14.71$15.35+4.35%$15.35$14.567,313 shs$90.41 million04/29/2024$14.47$14.71+1.66%$14.71$14.247,900 shs$86.64 million04/26/2024$14.52$14.47-0.34%$14.69$14.2510,910 shs$85.23 million Get the Latest News and Ratings for CRIS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Curis and its competitors with MarketBeat's FREE daily newsletter. 04/25/2024$14.77$14.52-1.69%$14.82$14.0710,246 shs$85.52 million04/24/2024$15.01$14.77-1.60%$15.12$14.714,734 shs$87.00 million04/23/2024$14.85$15.01+1.08%$15.01$14.615,784 shs$88.47 million04/22/2024$14.31$14.85+3.77%$14.85$14.0721,057 shs$87.47 million04/19/2024$15.22$14.31-5.98%$15.16$14.2610,124 shs$84.29 million04/18/2024$15.95$15.22-4.58%$16.50$14.6319,560 shs$89.65 million04/17/2024$15.27$15.95+4.45%$16.20$15.4936,493 shs$93.95 million04/16/2024$14.56$15.27+4.88%$15.27$14.1922,370 shs$89.94 million04/15/2024$15.28$14.56-4.71%$15.30$13.9920,188 shs$85.76 million04/12/2024$15.90$15.28-3.90%$16.24$14.928,007 shs$90.00 million04/11/2024$15.28$15.90+4.06%$16.06$14.8516,146 shs$93.65 million04/10/2024$15.58$15.28-1.93%$15.35$15.0013,014 shs$90.00 million04/09/2024$16.50$15.58-5.58%$16.58$14.8447,613 shs$91.83 million04/08/2024$16.80$16.50-1.79%$17.49$16.0140,389 shs$97.19 million04/05/2024$16.01$16.80+4.93%$16.80$15.0044,860 shs$98.95 million04/04/2024$13.40$16.01+19.48%$17.49$13.41314,538 shs$94.36 million04/03/2024$12.32$13.40+8.77%$13.40$11.3227,991 shs$78.93 million04/02/2024$12.68$12.32-2.84%$12.70$11.9537,770 shs$72.57 million04/01/2024$10.87$12.68+16.65%$12.68$10.6946,253 shs$74.69 million03/29/2024$10.87$10.87$10.95$10.4123,493 shs$64.07 million03/28/2024$10.87$10.87$10.95$10.4123,493 shs$64.02 million03/27/2024$10.19$10.87+6.67%$10.88$10.0839,856 shs$64.02 million03/26/2024$10.56$10.19-3.50%$10.83$10.0224,749 shs$60.02 million03/25/2024$10.80$10.56-2.22%$10.90$10.517,421 shs$62.20 million03/22/2024$10.83$10.80-0.28%$11.07$10.4216,055 shs$63.61 million03/21/2024$10.33$10.83+4.84%$10.99$10.2615,066 shs$63.79 million03/20/2024$10.22$10.33+1.08%$10.33$10.0316,212 shs$60.84 million03/19/2024$10.15$10.22+0.69%$10.40$10.017,235 shs$60.20 million03/18/2024$10.30$10.15-1.46%$10.30$10.1210,096 shs$59.78 million03/15/2024$10.19$10.30+1.08%$10.36$10.0711,360 shs$60.67 million03/14/2024$10.24$10.19-0.49%$10.49$9.9512,316 shs$60.02 million03/13/2024$10.02$10.24+2.20%$10.74$9.9126,668 shs$60.31 million03/12/2024$10.35$10.02-3.19%$10.46$10.0221,363 shs$59.02 million03/11/2024$10.50$10.35-1.43%$10.50$10.2111,389 shs$60.96 millionThe Gold Grab of the Century (Ad)When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide.03/08/2024$9.98$10.50+5.21%$10.50$9.9228,185 shs$61.85 million03/07/2024$9.76$9.98+2.25%$10.29$9.7512,238 shs$58.78 million03/06/2024$10.30$9.76-5.24%$10.62$9.7628,550 shs$57.49 million03/05/2024$9.70$10.30+6.14%$10.46$9.7026,298 shs$60.71 million03/04/2024$10.07$9.70-3.63%$10.36$9.7016,799 shs$57.16 million03/01/2024$10.19$10.07-1.18%$10.27$9.9020,966 shs$59.31 million02/29/2024$9.77$10.19+4.30%$10.55$9.7053,168 shs$60.02 million02/28/2024$10.01$9.77-2.40%$10.14$9.3919,904 shs$57.55 million02/27/2024$9.78$10.01+2.35%$10.26$9.2324,571 shs$58.96 million02/26/2024$9.51$9.78+2.84%$9.85$9.4025,184 shs$57.60 million02/23/2024$9.83$9.51-3.26%$9.99$9.1734,674 shs$56.01 million02/22/2024$10.27$9.83-4.28%$10.27$9.8230,816 shs$57.90 million02/21/2024$10.14$10.27+1.28%$10.35$10.0432,839 shs$60.49 million02/20/2024$10.49$10.14-3.34%$10.42$10.0812,037 shs$59.77 million02/19/2024$10.49$10.49$10.51$10.2034,400 shs$61.79 million02/16/2024$10.22$10.49+2.64%$10.51$10.2034,479 shs$61.79 million02/15/2024$10.29$10.22-0.68%$10.59$10.0518,004 shs$60.24 million02/14/2024$10.14$10.29+1.48%$10.31$9.7229,017 shs$60.61 million02/13/2024$10.72$10.14-5.41%$10.78$10.1414,815 shs$59.73 million02/12/2024$10.41$10.72+2.98%$11.25$10.5018,790 shs$63.14 million02/09/2024$10.65$10.41-2.25%$10.51$9.8814,699 shs$61.32 million02/08/2024$9.39$10.65+13.42%$10.65$9.29106,402 shs$62.73 million02/07/2024$9.42$9.39-0.32%$9.62$9.1718,264 shs$55.31 million02/06/2024$8.49$9.42+10.95%$9.53$8.4972,652 shs$55.48 million02/05/2024$10.25$8.49-17.17%$10.28$8.2496,592 shs$50.01 million Related Companies: Sangamo Therapeutics Stock Chart SAB Biotherapeutics Stock Chart X4 Pharmaceuticals Stock Chart Agenus Stock Chart AlloVir Stock Chart bluebird bio Stock Chart Protalix BioTherapeutics Stock Chart Vigil Neuroscience Stock Chart Atara Biotherapeutics Stock Chart Passage Bio Stock Chart Receive CRIS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Curis and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CRIS) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchStock-Picking AI Predicts #1 Stock of 2024AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlaceThe asset beating inflation by 4xColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Curis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.